Fig. 7From: Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysisEffect of roflumilast vs. placebo on TDI. CI, confidence interval; SD, standard derivation; TDI, transition dyspnea indexBack to article page